Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Esophageal Neoplasms 3 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Lymphatic Metastasis 1 High-Risk Cancer 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Gemcitabine 7 Cystectomy 5 Cisplatin 5 durvalumab 4 Neoadjuvant Therapy 4 Mitomycin 4 atezolizumab 3 Transurethral Resection of Bladder 3 Nivolumab 3 Epirubicin 3 Chemoradiotherapy 3 BCG Vaccine 3 Anesthesia, Spinal 3 tislelizumab 2 disitamab vedotin 2 catumaxomab 2 Vitamin E 2 Urinary Diversion 2 Sunitinib 2 Selenium 2 Robotic Surgical Procedures 2 Multiparametric Magnetic Resonance Imaging 2 Magnetic Resonance Imaging 2 Immunohistochemistry 2 Fentanyl 2 Docetaxel 2 Diathermy 2 Cystoscopy 2 Chemoprevention 2 BCG Connaught 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urinary Bladder Neoplasms × Radiotherapy, Adjuvant × Clear all

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡